Peter Batushansky - 09 Apr 2025 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Reporting relationship: Director
Issuer ticker: PETS
Reported as of: 09 Apr 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Apr 2025, 16:17:25 UTC
Next SEC filing: 03 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Peter Batushansky

Filing notes and source

Key filing fact

Peter Batushansky filed Form 4 for PETMED EXPRESS INC (PETS) on 11 Apr 2025.

Key facts

This page summarizes Peter Batushansky's Form 4 filing for PETMED EXPRESS INC (PETS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Apr 2025, 16:17.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value: $0
Shares: +2,527
Change %
Price: $0.000000
Shares after: 2,527
Date: 09 Apr 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") Non-Employee Director Equity Compensation Program, which vest on April 9, 2026, subject to continued service on the Board of Directors of the Company through the vesting period. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.